EyePoint Inc
EYPTHealthcare|Biotechnology|USA
$14.72
-0.12 (-0.81%)
Tangible Book
$2.76
About
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
Stock Price
+33.1%(1Y)
Pipeline Summary
20 total trials1
Phase 1
6
Phase 2
10
Phase 3
2
Phase 4
Completed: 11Recruiting: 3Withdrawn: 2Terminated: 2Active: 2
Active Trials (5)
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
NCT07449923Diabetic Macular Edema
Phase 3Recruiting
Enrollment: 240 participants
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
NCT05191706Cataract
Phase 4Recruiting
Enrollment: 60 participants
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
NCT06683742Wet Age Related Macular Degeneration
Phase 3Active
Enrollment: 400 participants
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
NCT07449936Diabetic Macular Edema
Phase 3Recruiting
Enrollment: 240 participants
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56
NCT06668064Wet Age Related Macular Degeneration
Phase 3Active
Enrollment: 400 participants
BioScore
4.6/10
Cautious
Ownership
Recent Insider Trades
Ribeiro RamiroSELL
2026-06-304,875 shares @ $15.01
Ribeiro RamiroSELL
2026-04-172,437 shares @ $15
Duker Jay S.BUY
2026-03-161,500 shares @ $13.15
Ribeiro RamiroSELL
2026-03-042,438 shares @ $17.87
Ribeiro RamiroSELL
2026-02-172,437 shares @ $15
Recent News
2026-07-08 15:49:59
2026-07-01 13:33:39
2026-06-24 14:37:07
Data last updated: Jul 13, 2026, 12:47 PM